Mesoblast Ltd.

Mesoblast Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.25
Market Cap
AUD715.46 M
Shares Outstanding
498.63 M
Public Float
371.7 M
Mesoblast Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$0.92
Market Cap
$527.8 M
Shares Outstanding
99.73 M
Public Float
-

Profile

Address
55 Collins Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.mesoblast.com
Updated 07/08/2019
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Financials

View All

Silviu Itescu
Chief Executive Officer, MD & Executive Director
Shawn Cline Tomasello
Director